InvestorsHub Logo
Followers 43
Posts 2995
Boards Moderated 0
Alias Born 12/29/2013

Re: FALCON1 post# 806

Wednesday, 03/08/2017 9:11:15 AM

Wednesday, March 08, 2017 9:11:15 AM

Post# of 27649
Good stuff , really like this.
Quote: One major challenge in the vaccination field is the necessity to keep the vaccines cooled for preserving their stability, safety and effectiveness, which represents a huge challenge for providing vaccination access to populations living in areas with limited infrastructure. If MACIVIVA is successful for developing thermostable virosomal vaccines suitable for storage under all world climates, the perspective may therefore:
- Raise high interest from major stakeholders;
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News